• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TEVA PHARMACEUTICALS USA PARAGARD; DEVICE, INTRAUTERINE, CONTRACEPTIVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TEVA PHARMACEUTICALS USA PARAGARD; DEVICE, INTRAUTERINE, CONTRACEPTIVE Back to Search Results
Lot Number 513002
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 03/07/2016
Type of Reportable Event Malfunction
Event or Problem Description
The iud made of copper broke apart in the patient.During out-patient surgery, the device was removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PARAGARD
Common Device Name
DEVICE, INTRAUTERINE, CONTRACEPTIVE
Manufacturer (Section D)
TEVA PHARMACEUTICALS USA
1090 horsham rd.
north wales PA 19454
MDR Report Key5515917
Report Number5515917
Device Sequence Number11969611
Product Code HDT
Combination Product (Y/N)N
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2014
Device Explanted Year2016
Reporter Type User Facility
Type of Report Initial
Report Date (Section B) 03/09/2016
Report Date (Section F) 03/09/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device No Information
Device Expiration Date01/01/2020
Device Lot Number513002
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? Yes
Device Age2 YR
Event Location Hospital
Date Report to Manufacturer03/09/2016
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date03/22/2016
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age20 YR
Date Report Sent to FDA03/09/2016
-
-